Levisonics
IN - FishersBiotechnology
Focus: Levisonics develops a novel platform for blood coagulation analysis and fluid rheological measurement, targeting hematology applications. As a public biotech founded in 2016, the company operates in a specialized diagnostic/device segment with limited disclosed scale.
Profile data last refreshed 3h ago · AI intelligence enriched 3w ago
Funding Stage
PUBLIC
Open Jobs
5
Should You Work at Levisonics?
AI assessmentLevisonics is a high-risk, potentially high-reward early-stage play best suited for risk-tolerant professionals seeking hands-on diagnostic platform development with meaningful equity exposure.
Why Work Here
- Early-stage public company (founded 2016) with potential for meaningful equity upside in a focused hematology platform play
- Only 5 active roles suggest tight, mission-driven team with direct impact on product development and strategy
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Levisonics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.